000 | 01951 a2200553 4500 | ||
---|---|---|---|
005 | 20250513092201.0 | ||
264 | 0 | _c19960809 | |
008 | 199608s 0 0 eng d | ||
022 | _a0160-9289 | ||
024 | 7 |
_a10.1002/clc.4960190313 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGebara, O C | |
245 | 0 | 0 |
_aStress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: effect of verapamil. _h[electronic resource] |
260 |
_bClinical cardiology _cMar 1996 |
||
300 |
_a205-11 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCalcium Channel Blockers _xadministration & dosage |
650 | 0 | 4 |
_aCollagen _xpharmacology |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aEpinephrine _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPlacebos |
650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
650 | 0 | 4 | _aPosture |
650 | 0 | 4 |
_aStress, Physiological _xphysiopathology |
650 | 0 | 4 |
_aStress, Psychological _xphysiopathology |
650 | 0 | 4 |
_aVasodilator Agents _xadministration & dosage |
650 | 0 | 4 |
_aVerapamil _xadministration & dosage |
700 | 1 | _aJimenez, A H | |
700 | 1 | _aMcKenna, C | |
700 | 1 | _aMittleman, M A | |
700 | 1 | _aXu, P | |
700 | 1 | _aLipinska, I | |
700 | 1 | _aMuller, J E | |
700 | 1 | _aTofler, G H | |
773 | 0 |
_tClinical cardiology _gvol. 19 _gno. 3 _gp. 205-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/clc.4960190313 _zAvailable from publisher's website |
999 |
_c8672101 _d8672101 |